Insulet Corporation (PODD) Sector
Health Care

(Current) $277.59
1.17 (0.42%) Open Price: 273.47

Insulet Corporation is a medical device company that specializes in the development and manufacturing of innovative insulin delivery systems for people with diabetes. The company is known for its flagship product, the Omnipod System, which provides a tubeless and wireless insulin delivery option for diabetic patients. Founded in 2000, Insulet has rapidly grown to become a major player in the diabetes management market.

The history of Insulet Corporation can be traced back to its inception in 2000, when John Brooks, a father of a child with diabetes, sought to create a better insulin delivery system for his son. He founded the company with the vision of developing a more user-friendly, discreet, and hassle-free insulin pump. This led to the creation of the Omnipod System, which received FDA approval in 2005 and was introduced to the market in 2006.

The Omnipod System is a unique insulin management solution that eliminates the need for traditional insulin pump tubing. It consists of a small, waterproof, and disposable insulin pod that adheres to the user's body and delivers insulin through a tiny, flexible cannula. The pod is controlled wirelessly by a handheld Personal Diabetes Manager (PDM) device, allowing users to manage their insulin delivery discreetly and conveniently.

Insulet's Omnipod System has gained popularity among diabetes patients due to its tubeless and wireless design, making it more comfortable and less intrusive in daily life. The system has been praised for its ease of use, discretion, and flexibility, as users can wear the pod under clothing, allowing for a more active and unrestricted lifestyle.

(12/11/24) $273.47
(12/12/24) $276.42
(12/12/24) (Qty.)171,674
(12/11/24) $273.17
(12/11/24) $279.39
(12/08/24) $263.18
(12/08/24) $279.39
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing